214 related articles for article (PubMed ID: 11650684)
21. Recombinant DNA Advisory Committee: minutes of meeting, 3 Oct 1988.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Recomb DNA Tech Bull; 1988 Dec; 11(4):155-94. PubMed ID: 11644344
[No Abstract] [Full Text] [Related]
22. Biotechnology and culture: the impact of public debates on government regulation in the United States and Denmark.
Baark E; Jamison A
Technol Soc; 1990; 12(1):27-44. PubMed ID: 11650912
[No Abstract] [Full Text] [Related]
23. Recombinant DNA research; availability of environmental assessment for public comment; request for comments on need for a programmatic environmental impact statement; notice.
U.S. National Institutes of Health
Fed Regist; 1985 Apr; 50(72):14794-6. PubMed ID: 11645548
[No Abstract] [Full Text] [Related]
24. Recombinant DNA research: proposed actions under the guidelines; notice.
U.S. National Institutes of Health
Fed Regist; 1996 Nov; 61(227):59726-42. PubMed ID: 11645326
[No Abstract] [Full Text] [Related]
25. White House to release biotechnology guidelines.
Sun M
Science; 1986 Jun; 232(4755):1189. PubMed ID: 11643922
[No Abstract] [Full Text] [Related]
26. Embryo research tests NIH's mettle.
Gavaghan H
Nat Med; 1995 Jan; 1(1):5-6. PubMed ID: 11644731
[No Abstract] [Full Text] [Related]
27. Recombinant DNA research; actions under guidelines; notice of actions.
U.S. National Institutes of Health
Fed Regist; 1986 May; 51(88):16952-6. PubMed ID: 11655846
[No Abstract] [Full Text] [Related]
28. Institutional biosafety committees and the inadequacies of risk regulation.
Bereano PL
Sci Technol Human Values; 1984; 9(4):16-34. PubMed ID: 11649608
[No Abstract] [Full Text] [Related]
29. Recombinant DNA research; actions under guidelines; notice.
U.S. National Institutes of Health
Fed Regist; 1984 Apr; 49(81):17844-8. PubMed ID: 11655581
[No Abstract] [Full Text] [Related]
30. Recombinant DNA research; proposed actions under guidelines.
U.S. National Institutes of Health
Fed Regist; 1985 Dec; 50(245):52176-8. PubMed ID: 11655732
[No Abstract] [Full Text] [Related]
31. Regulatory structure for biotechnology proposed.
Sun M
Science; 1985 Jan; 227(4684):274. PubMed ID: 11643694
[TBL] [Abstract][Full Text] [Related]
32. Recombinant DNA research; actions under guidelines; notice.
U.S. National Institutes of Health
Fed Regist; 1984 Sep; 49(179):36052-60. PubMed ID: 11655750
[No Abstract] [Full Text] [Related]
33. State biotechnology oversight: the juncture of technology, law, and public policy.
Vito CC
Maine Law Rev; 1993; 45(2):329-83. PubMed ID: 11652701
[No Abstract] [Full Text] [Related]
34. Recombinant DNA and technology assessment.
Georgetown Law J; 1977; 11(4):785-878. PubMed ID: 11664859
[No Abstract] [Full Text] [Related]
35. Recombinant DNA research: actions under the guidelines; notice.
U.S. National Institutes of Health
Fed Regist; 1995 Apr; 60(81):20726-37. PubMed ID: 11656763
[No Abstract] [Full Text] [Related]
36. Recombinant DNA research: proposed actions under the guidelines.
U.S. National Institutes of Health
Fed Regist; 1997 Aug; 62(161):44387-90. PubMed ID: 11658086
[No Abstract] [Full Text] [Related]
37. Biotechnology: new plans for regulation.
Beardsley T
Nature; 1985 Oct; 317(6036):373. PubMed ID: 11653653
[No Abstract] [Full Text] [Related]
38. From Asilomar to industrial biotechnology: risks, reductionism and regulation.
Krimsky S
Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467
[No Abstract] [Full Text] [Related]
39. Biotech firms win approval for more open-air tests.
Joyce C
New Sci; 1984 Jun; 102(1413):4. PubMed ID: 11655646
[No Abstract] [Full Text] [Related]
40. NIH committee sheds darkness on UCSD case.
Wade N
Science; 1981 Apr; 212(4490):27. PubMed ID: 11643634
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
